Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.38 |
| ▸ | MAPT | P10636 | 7/20 | 0.38 |
| ▸ | HPGD | P15428 | 6/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 3/20 | 0.32 |
| ▸ | MAOB | P27338 | 3/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21969898 | 0.99 | MEN1 (0.37) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908630 | 0.98 | MEN1 (0.36) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908626 | 0.97 | MEN1 (0.35) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908620 | 0.97 | MEN1 (0.35) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908655 | 0.97 | MEN1 (0.35) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL21867774 | 0.96 | MEN1 (0.34) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL22763820 | 0.96 | MEN1 (0.34) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908625 | 0.95 | MEN1 (0.34) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908656 | 0.94 | MEN1 (0.39) | MEN1KMT2AMAPTHPGDALDH1A1 | |
| SCHEMBL15908666 | 0.94 | DUSP3 (0.34) | MEN1KMT2AMAPTHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388767-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-10 | — | — | US | disclosed |
| US-20200388768-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-10 | — | — | US | disclosed |
| US-10461258-B2 | Compound | IDEMITSU KOSAN CO., LTD. (JP) | 2019-10-29 | — | — | US | disclosed |
| US-20190006598-A1 | NOVEL COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-01-03 | — | — | US | disclosed |
| EP-2862862-B1 | ORGANIC LIGHT EMITTING DEVICE COMPRISING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | LG CHEMICAL LTD (KR) | 2019-01-02 | — | — | EP | disclosed |
| US-20170186968-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186968-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9203033-B2 | Nitrogen-containing heterocyclic compounds and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2015-12-01 | — | — | US | disclosed |
| US-9203033-B2 | Nitrogen-containing heterocyclic compounds and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2015-12-01 | — | — | US | disclosed |
| US-20140209884-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20140209884-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2014-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190006598-A1 | NOVEL COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, L1CAM, TMEM109 | MEN1 587/4885KMT2A 2181/4885MAPT 1535/4885 |
| US-10461258-B2 | Compound | CYP19A1, CYP17A1, CYP51A1 | MEN1 202/4885KMT2A 1639/4885MAPT 3321/4885 |
| US-20170186968-A1 | NOVEL COMPOUND | SREBF1, BRIX1, SREBF2 | MEN1 2873/4885KMT2A 3156/4885MAPT 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.